Publicacións (61) Publicacións de LUIS MIGUEL BEDOYA DEL OLMO

2024

  1. Maca (Lepidium meyenii Walp.) inhibits HIV-1 infection through the activity of thiadiazole alkaloids in viral integration

    Journal of Ethnopharmacology, Vol. 335

  2. Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation?

    EJNMMI Radiopharmacy and Chemistry, Vol. 9, Núm. 1

2023

  1. A new hydrogel containing a proanthocyanidin polymer-rich extract of Commiphora leptophloeos for treating vulvovaginal candidiasis: Preclinical results using the alternative model of Galleria mellonella

    Journal of Drug Delivery Science and Technology, Vol. 85

  2. Exploring the HIV-1 Rev Recognition Element (RRE)–Rev Inhibitory Capacity and Antiretroviral Action of Benfluron Analogs

    Molecules, Vol. 28, Núm. 20

  3. Novel HIV-1 RNA biogenesis inhibitors identified by virtual pharmacophore-based screening

    Biochemical Pharmacology, Vol. 215

  4. Participación y género en las facultades de ciencias de la salud de la UCM

    Miradas a la participación y al género en las aulas universitarias: una guía para docentes (Los Libros de la Catarata), pp. 104-116

  5. Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis

    AIDS Research and Human Retroviruses

2022

  1. Layer-by-layer vaginal films for acyclovir controlled release to prevent genital herpes

    International Journal of Pharmaceutics, Vol. 627

2021

  1. Smart vaginal bilayer films of Tenofovir based on Eudragit® L100/natural polymer for the prevention of the sexual transmission of HIV

    International journal of pharmaceutics, Vol. 602, pp. 120665

  2. Withanolide-Type Steroids from Physalis nicandroides Inhibit HIV Transcription

    Journal of Natural Products, Vol. 84, Núm. 10, pp. 2717-2726

2020

  1. 4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat

    Biochemical Pharmacology, Vol. 177

  2. Amino functionalized micro-mesoporous hybrid particles for the sustained release of the antiretroviral drug tenofovir

    Materials, Vol. 13, Núm. 16

  3. Development and In Vitro/Ex Vivo Characterization of Vaginal Mucoadhesive Bilayer Films Based on Ethylcellulose and Biopolymers for Vaginal Sustained Release of Tenofovir

    Biomacromolecules, Vol. 21, Núm. 6, pp. 2309-2319

  4. Ethanolic extract of Artemisia campestris subsp. glutinosa (Besser) Batt. inhibits HIV–1 replication in vitro through the activity of terpenes and flavonoids on viral entry and NF–κB pathway

    Journal of Ethnopharmacology, Vol. 263

  5. Nucleic acid recognition and antiviral activity of 1,4-substituted terphenyl compounds mimicking all faces of the HIV-1 Rev protein positively-charged α-helix

    Scientific Reports, Vol. 10, Núm. 1

  6. Vaginal polyelectrolyte layer-by-layer films based on chitosan derivatives and Eudragit® S100 for pH responsive release of tenofovir

    Marine Drugs, Vol. 18, Núm. 1

2019

  1. Dapivirine bioadhesive vaginal tablets based on natural polymers for the prevention of sexual transmission of HIV

    Polymers, Vol. 11, Núm. 3

  2. Development of mucoadhesive vaginal films based on HPMC and zein as novel formulations to prevent sexual transmission of HIV

    International Journal of Pharmaceutics, Vol. 570

  3. Freeze-dried bioadhesive vaginal bigels for controlled release of Tenofovir

    European Journal of Pharmaceutical Sciences, Vol. 127, pp. 38-51

2018

  1. A small-molecule inhibitor of HIV-1 Rev function detected by a diversity screen based on RRE-Rev interference

    Biochemical Pharmacology, Vol. 156, pp. 68-77